<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Long-Acting Monoclonal Antibodies Look Promising for COVID-19 Prevention

Default sub title

minute read

by Endocrinology Advisor | August 24, 2021
placeholder

Positive topline results were announced from a phase 3 study evaluating the efficacy and safety of AZD7442 for the prevention of COVID-19.

Topics: Press Coverage